By Jos Truitt • @jostruitt • 11 years ago

What We Missed

The FDA has approved the first drug shown to reduce the risk of HIV infection.

I have no idea what it says, but if you read French here’s the text of a speech Chloe gave in Paris recently.

The New York Times has named Margaret M. Sullivan as their new public editor, and she’s a lady!

Florida Lieutenant Governor Jennifer Carroll: “Usually black women that look like me don’t engage in [lesbian relationships].” Um, no.

Following up our story about a Brazilian airline that kicked a passenger off for making sexist comments to the pilot, someone was kicked off their flight for calling an airline employee a “f*ggot.”

Boston, MA

Jos Truitt is Executive Director of Development at Feministing. She joined the team in July 2009, became an Editor in August 2011, and Executive Director in September 2013. She writes about a range of topics including transgender issues, abortion access, and media representation. Jos first got involved with organizing when she led a walk out against the Iraq war at her high school, the Boston Arts Academy. She was introduced to the reproductive justice movement while at Hampshire College, where she organized the Civil Liberties and Public Policy Program’s annual reproductive justice conference. She has worked on the National Abortion Federation’s hotline, was a Field Organizer at Choice USA, and has volunteered as a Pro-Choice Clinic Escort. Jos has written for publications including The Guardian, Bilerico, RH Reality Check, Metro Weekly, and the Columbia Journalism Review. She has spoken and trained at numerous national conferences and college campuses about trans issues, reproductive justice, blogging, feminism, and grassroots organizing. Jos completed her MFA in Printmaking at the San Francisco Art Institute in Spring 2013. In her "spare time" she likes to bake and work on projects about mermaids.

Jos Truitt is an Executive Director of Feministing in charge of Development.

Read more about Jos

Join the Conversation